A recent study following a meningitis vaccination campaign in Burkina Faso, Africa investigated when a booster vaccination might be necessary.

The African meningitis belt encompassing the sub-Saharan African and is plagued by recurrent epidemics of meningococcal meningitis a lethal bacterial infection that affects the brain and spinal cord. The vaccination campaign has resulted in a significant reduction of Neisseria Meningitidis- associated meningitis.

“In conclusion, the current study found a steady decline in antibody levels following a single dose of the meningitis vaccine and suggests the eventual need for a vaccine booster in the future.”

Read the full story here